Tata Medical and Diagnostics (TataMD) on Wednesday announced a collaboration with Chennai-based Anderson Diagnostics & Labs to standardise its indigenously developed diagnostic kit for testing Covid-19 infections.
TataMD CHECK follows guidelines set by India’s drug regulator and ADL has used it for over 10,000 Covid-19 tests, said the Tata group’s healthcare venture.
The kit offers a clear, quicker and more accessible alternative to RT-PCR, India’s mainstay for Covid-19 tests. It can be used for detecting and treatment of a number of other diseases as well, said the company.
"Our clinical partnership with TataMD will help support the transformation of Covid

)